SI9300011A - Hemoregulatory peptides - Google Patents

Hemoregulatory peptides Download PDF

Info

Publication number
SI9300011A
SI9300011A SI19939300011A SI9300011A SI9300011A SI 9300011 A SI9300011 A SI 9300011A SI 19939300011 A SI19939300011 A SI 19939300011A SI 9300011 A SI9300011 A SI 9300011A SI 9300011 A SI9300011 A SI 9300011A
Authority
SI
Slovenia
Prior art keywords
acid
tyrosine
lys
asp
glutamine
Prior art date
Application number
SI19939300011A
Other languages
English (en)
Slovenian (sl)
Inventor
Pradip Kumar Bhatnagar
William Francis Huffman
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of SI9300011A publication Critical patent/SI9300011A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI19939300011A 1992-01-10 1993-01-08 Hemoregulatory peptides SI9300011A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81902492A 1992-01-10 1992-01-10

Publications (1)

Publication Number Publication Date
SI9300011A true SI9300011A (en) 1993-09-30

Family

ID=25227024

Family Applications (1)

Application Number Title Priority Date Filing Date
SI19939300011A SI9300011A (en) 1992-01-10 1993-01-08 Hemoregulatory peptides

Country Status (14)

Country Link
EP (1) EP0621788B1 (zh)
JP (1) JPH07505864A (zh)
CN (1) CN1077960A (zh)
AT (1) ATE201693T1 (zh)
AU (1) AU666516B2 (zh)
CA (1) CA2127688A1 (zh)
DE (1) DE69330268T2 (zh)
ES (1) ES2159287T3 (zh)
IL (1) IL104323A0 (zh)
MX (1) MX9300100A (zh)
NZ (1) NZ246805A (zh)
SI (1) SI9300011A (zh)
WO (1) WO1993013789A1 (zh)
ZA (1) ZA93129B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69420044T2 (de) * 1993-10-29 2000-03-23 Smithkline Beecham Corp., King Of Prussia Blutregulierende peptide
GB9425730D0 (en) * 1994-12-20 1995-02-22 Nycomed Pharma As Compounds
JP2000500461A (ja) * 1995-11-13 2000-01-18 スミスクライン・ビーチャム・コーポレイション 血液調節化合物
US5767135A (en) * 1995-12-29 1998-06-16 Fernandez-Pol; Jose Alberto Antiviral agent
US6579891B1 (en) 1995-12-29 2003-06-17 Novactyl, Inc. Agent and method for prevention and treatment of cancer in animals
US6743771B2 (en) 1995-12-29 2004-06-01 Novactyl, Inc. Methods and compositions for controlling protein assembly or aggregation
US6127393A (en) 1995-12-29 2000-10-03 Novactyl, Inc. Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method
US6407125B1 (en) 1995-12-29 2002-06-18 Novactyl, Inc. Pharmacological agent and method of treatment
US6441009B1 (en) 1998-08-01 2002-08-27 Novactyl, Inc. Agent and method of preventing and treating heavy metal exposure and toxicity
US6403618B1 (en) 2000-02-15 2002-06-11 Novactyl, Inc. Agent and method for controlling angiogenesis
FR2966827B1 (fr) 2010-10-27 2014-08-22 Kimonella Ventures Ltd Compose peptidique utile pour l'inhibition de la formation de plaques amyloides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA838780B (en) * 1982-11-26 1985-01-30 Nyegaard & Co As Peptide compounds
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds
NO884054D0 (no) * 1988-09-13 1988-09-13 Bio Tech As Nytt pentapeptid og fremgangsmaate for fremstilling derav.
GB8821785D0 (en) * 1988-09-16 1988-10-19 Nycomed As Peptide compounds
ZW11290A1 (en) * 1989-07-14 1990-10-31 Smithkline Beecham Corp Hemoregulatory peptides
GB9211677D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
AU4340393A (en) * 1992-06-02 1993-12-30 Hafslund Nycomed As Double chain peptide compounds having hemoregulatory activity

Also Published As

Publication number Publication date
MX9300100A (es) 1994-04-29
AU666516B2 (en) 1996-02-15
NZ246805A (en) 1995-12-21
CA2127688A1 (en) 1993-07-22
ES2159287T3 (es) 2001-10-01
EP0621788A4 (en) 1997-03-05
AU3440293A (en) 1993-08-03
EP0621788B1 (en) 2001-05-30
EP0621788A1 (en) 1994-11-02
DE69330268D1 (de) 2001-07-05
CN1077960A (zh) 1993-11-03
WO1993013789A1 (en) 1993-07-22
JPH07505864A (ja) 1995-06-29
ATE201693T1 (de) 2001-06-15
IL104323A0 (en) 1993-05-13
ZA93129B (en) 1994-01-18
DE69330268T2 (de) 2001-11-22

Similar Documents

Publication Publication Date Title
CA1236786A (en) Peptide compounds
WO1994027627A1 (en) Hemoregulatory peptides
EP0408371B1 (en) Hemoregulatory peptides
SI9300011A (en) Hemoregulatory peptides
JPH02500517A (ja) ペプチド化合物
AP317A (en) Hemoregulatory peptides.
US5620957A (en) Hemoregulatory peptides
EP0725651B1 (en) Hemoregulatory peptides
CN102477078B (zh) 胸腺体液因子(THF)-γ2改构肽的制备及其药物组合物的用途
CN101407539B (zh) 保护骨髓造血功能寡肽,其制法和药物组合物与用途